UnknownNot Applicable

Comparison of Two Kinds of Biliary Intestinal Reconstruction in Cholangiectasia

China120 participantsStarted 2017-06-01

Plain-language summary

To observe and compare the short-term and long-term effects of different biliary and intestinal reconstruction methods for the treatment of congenital cystic dilatation of bile duct .

Who can participate

Age range5 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. gender, age 5-70 years old (the disease can occur at any age, but in 80% cases of childhood onset, such as children's height and weight of endoscopic treatment for the standard, by parents as guardians into the group);
✓. preoperative congenital cystic dilatation of the bile duct (I, II, IV) clear diagnosis; preoperative assessment of liver function
✓. : Child-Pugh = B;
✓. bile duct without canceration;
✓. recurrent cholangitis, biliary calculi in the biliary tract infection was controlled in acute pancreatitis; control of inflammation;
✓. the treatment of choledochal cyst, without any surgical treatment;
✓. the general condition of the patient, heart and lung function can tolerate surgery, no absolute contraindication abdominal laparoscopic operation;
✓. voluntarily participated in the study, informed consent.

Exclusion criteria

✕. congenital cystic dilatation of the bile duct of III type, V type (III type feasible endoscope end of bile duct duodenal sphincterotomy, V type partial resection of the liver);
✕. patients who cannot tolerate pneumoperitoneum or serious abdominal adhesions, unable to carry out laparoscopic surgery;
✕. bad general condition or heart pulmonary dysfunction cannot tolerate surgery;
✕. severe cholestatic cirrhosis, severe portal hypertension;
✕. high risk patients with general anesthesia.

What they're measuring

operation time

Timeframe: 2 years

Trial details

NCT IDNCT03401424

SponsorSouthwest Hospital, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06-01

Contact for this trial

Shuguo Zheng

0086-13508308676 shuguozh@yahoo.com.cn

View on ClinicalTrials.gov More Postcholecystectomy Syndrome trials